Salt and Nitric Oxide Synthase Inhibition-Induced Hypertension: Kidney Dysfunction and Brain Anti-Oxidant Capacity

dc.contributor.authorOktar, Suleyman
dc.contributor.authorIlhan, Selcuk
dc.contributor.authorMeydan, Sedat
dc.contributor.authorAydin, Mehmet
dc.contributor.authorYonden, Zafer
dc.contributor.authorGokce, Ahmet
dc.date.accessioned2026-08-12T17:30:33Z
dc.date.issued2010
dc.departmentFırat Üniversitesi
dc.description.abstractThe specific aim of this study was to examine the effects of salt-loading on kidney function and brain antioxidant capacity. Wistar rats were divided into four groups: Control rats were given normal drinking water and no drug treatment for 2 weeks. LNNA group: rats were given normal drinking water and the nitric oxide (NO) inhibitor NG-nitro-L-arginine (L-NNA), 3 mg/kg/day. LNNA + Salt group: rats were given drinking water containing salt 2% and 3 mg/kg L-NNA. Salt group: rats were given drinking water containing salt 2% and no drug treatment. Basal blood pressure and the levels of serum BUN, creatinine, uric acid, cortisol, electrolyte, serum antioxidant capacity, and oxidative stress were measured. NO, superoxide dismutase (SOD), and catalase (CAT) levels were measured in the hypothalamus, brainstem, and cerebellum. Salt overload increased the blood pressure of the LNNA + Salt group. Salt-loading enhanced BUN, creatinine, sodium retention. High salt produced an increase in uric acid levels and a decrease in cortisol levels in serum. Additionally, the oxidative stress index in serum increased in the LNNA + Salt group. Salt-loading enhanced brain NO levels, but not SOD and CAT activity. L-NNA increased brain SOD activity, but not CAT and NO levels. In conclusion, salt-loading causes hypertension, kidney dysfunction, and enhances oxidative stress in salt-sensitive rats.
dc.description.sponsorshipMustafa Kemal University [08T1502]
dc.description.sponsorshipThis study was supported by the Research Fund of Mustafa Kemal University (08T1502).
dc.identifier.doi10.3109/10641961003628486
dc.identifier.endpage357
dc.identifier.issn1064-1963
dc.identifier.issn1525-6006
dc.identifier.issue6
dc.identifier.orcid0000-0003-0151-5981
dc.identifier.orcid0000-0003-0708-5417
dc.identifier.orcid0000-0002-1393-3235
dc.identifier.pmid21028998
dc.identifier.scopus2-s2.0-78049418484
dc.identifier.scopusqualityQ2
dc.identifier.startpage352
dc.identifier.urihttps://doi.org/10.3109/10641961003628486
dc.identifier.urihttps://hdl.handle.net/11508/56143
dc.identifier.volume32
dc.identifier.wosWOS:000283593900006
dc.identifier.wosqualityQ2
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherTaylor & Francis Inc
dc.relation.ispartofClinical and Experimental Hypertension
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WoS_20260511
dc.subjectkidney
dc.subjecthypertension
dc.subjectoxidative stress
dc.subjectsuperoxide dismutase
dc.subjectsalt
dc.titleSalt and Nitric Oxide Synthase Inhibition-Induced Hypertension: Kidney Dysfunction and Brain Anti-Oxidant Capacity
dc.typeArticle

Dosyalar